help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, J. H.
Right arrow Articles by Macdonald, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J. H.
Right arrow Articles by Macdonald, R. G.

Endocrinology, Vol 126, 2998-3005, Copyright © 1990 by Endocrine Society


ARTICLES

Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line

JH Park, JA Vanderhoof, D Blackwood and RG Macdonald
Department of Pediatrics, Creighton University, Omaha, Nebraska.

Insulin-like growth factors (IGFs) and insulin stimulate DNA and protein synthesis in IEC-6 cells (an intestinal epithelial cell line) grown in a chemically defined medium. IGF-I stimulates proliferation of IEC-6 cells at a lower concentration (ED50 = 1.6 nM) than either insulin or IGF-II. To gain insight into the mechanisms by which IGFs stimulate IEC-6 cell growth, we have examined the characteristics of specific IGF receptors on IEC-6 cells. Binding of 125I-IGF-I and 125I- IGF-II to IEC-6 monolayers was analyzed by incubation with various concentrations (0.2 nM to 0.5 microM) of radiolabeled IGFs for 16 h at 3 C. Scatchard plots of 125I-IGF-I binding were linear, suggesting a single class of binding sites with KD = 3.1 +/- 0.35 nM and Bmax = 50.7 +/- 6 fmol/10(6) cells. IGF-II was potent in displacing 125I-IGF-I (KI = 8.1 +/- 0.85 nM), but insulin had little effect. Affinity cross- linking with 125I-IGF-I followed by sodium dodecyl sulfate- polyacrylamide gel electrophoresis revealed three bands with Mr of 270,000, 245,000, and 133,000, and the major band was the 133,000 species. Labeling of the 133,000 and 270,000 bands was greater than or equal to 80% inhibited by 10(-7) M unlabeled IGF-I, less potently inhibited by IGF-II and not at all by insulin. These results suggest that the 133,000 band represents the alpha-subunit of the type I IGF receptor. Scatchard plots of 125I-IGF-II binding to IEC-6 cell monolayers were curvilinear, suggesting two classes of binding sites: high affinity, low capacity sites, KD = 0.87 +/- 0.08 nM and Bmax = 28 +/- 2.5 fmol/10(6) cells; low affinity, high capacity sites, KD = 60 = +/- 8.8 nM and Bmax = 1780 +/- 230 fmol/10(6) cells. Neither IGF-I nor insulin was effective in inhibiting 125I-IGF-II binding. Affinity cross- linking with 125I-IGF-II labeled predominantly a 245,000 band, suggesting that this species is the type II receptor. A band with Mr 131,000 was barely detectable with 125I-insulin. These results indicate that IEC-6 cells have abundant quantities of the type I and II IGF receptors and few insulin receptors, suggesting that the mitogenic effect of IGFs is mediated through the type I IGF receptor.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Pascual, I. Castilla-Cortazar, E. Urdaneta, J. Quiroga, M. Garcia, A. Picardi, and J. Prieto
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I
Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G319 - G324.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Patel, E. C. M. B.-V. d. Linden, S. W. Altmann, K. Gish, S. Balasubramanian, J. C. Timans, D. Peterson, M. P. Bell, J. F. Bazan, A. Varki, et al.
OB-BP1/Siglec-6. A LEPTIN- AND SIALIC ACID-BINDING PROTEIN OF THE IMMUNOGLOBULIN SUPERFAMILY
J. Biol. Chem., August 6, 1999; 274(32): 22729 - 22738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. M. Jehle, R. D. Fussgaenger, N. K. O. Angelus, R. J. Jungwirth, B. Saile, and M. P. Lutz
Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E262 - E268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. Castilla-Cortazar, A. Picardi, A. Tosar, J. Ainzua, E. Urdaneta, M. Garcia, M. Pascual, J. Quiroga, and J. Prieto
Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats
Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G37 - G42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Nishimura, M. Fujimoto, S. Oguchi, R. D. Fusunyan, R. P. MacDermott, and I. R. Sanderson
Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells
Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E55 - E63.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. L. Garrouste, M. M. Remacle-Bonnet, M. M.-A. Lehmann, J. L. Marvaldi, and G. J. Pommier
Up-Regulation of Insulin/Insulin-Like Growth Factor-I Hybrid Receptors during Differentiation of HT29-D4 Human Colonic Carcinoma Cells
Endocrinology, May 1, 1997; 138(5): 2021 - 2032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society